HUP0003831A2 - Szövetfaktor alkalmazása véredényképződés befolyásolására - Google Patents

Szövetfaktor alkalmazása véredényképződés befolyásolására

Info

Publication number
HUP0003831A2
HUP0003831A2 HU0003831A HUP0003831A HUP0003831A2 HU P0003831 A2 HUP0003831 A2 HU P0003831A2 HU 0003831 A HU0003831 A HU 0003831A HU P0003831 A HUP0003831 A HU P0003831A HU P0003831 A2 HUP0003831 A2 HU P0003831A2
Authority
HU
Hungary
Prior art keywords
blood vessel
tissue factor
vessel formation
influencing blood
influencing
Prior art date
Application number
HU0003831A
Other languages
English (en)
Inventor
Katsumi Nakagawa
Peter Nawroth
Youming Zhang
Original Assignee
Merckle Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh. filed Critical Merckle Gmbh.
Publication of HUP0003831A2 publication Critical patent/HUP0003831A2/hu
Publication of HUP0003831A3 publication Critical patent/HUP0003831A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

A találmány tárgya szövetfaktor alkalmazása a véredényképződésbefolyásolására, különösen aktiválására, főleg sebgyógyulás során. Ó
HU0003831A 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation HUP0003831A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19719652A DE19719652A1 (de) 1997-05-09 1997-05-09 Tissue-Faktor zur Förderung von Wundheilung
DEPCT/DE98/01278 1998-05-07

Publications (2)

Publication Number Publication Date
HUP0003831A2 true HUP0003831A2 (hu) 2001-02-28
HUP0003831A3 HUP0003831A3 (en) 2003-08-28

Family

ID=7829124

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003831A HUP0003831A3 (en) 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation

Country Status (16)

Country Link
EP (1) EP0980251B1 (hu)
JP (1) JP2001527555A (hu)
AT (1) ATE222501T1 (hu)
AU (1) AU746782B2 (hu)
CA (1) CA2288117A1 (hu)
CZ (1) CZ293005B6 (hu)
DE (2) DE19719652A1 (hu)
DK (1) DK0980251T3 (hu)
ES (1) ES2184299T3 (hu)
HU (1) HUP0003831A3 (hu)
IS (1) IS5231A (hu)
NO (1) NO995459L (hu)
PL (1) PL336662A1 (hu)
PT (1) PT980251E (hu)
SI (1) SI0980251T1 (hu)
WO (1) WO1998051321A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
WO1994005328A1 (en) * 1992-08-28 1994-03-17 The Scripps Research Institute Inhibition of tumor metastasis via neutralization of tissue factor function
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
DK0804562T3 (da) * 1994-07-12 2003-02-10 Human Genome Sciences Inc Bindevævsvækstfaktor-2
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Also Published As

Publication number Publication date
DE59805246D1 (de) 2002-09-26
CZ293005B6 (cs) 2004-01-14
IS5231A (is) 1999-10-26
PL336662A1 (en) 2000-07-03
HUP0003831A3 (en) 2003-08-28
AU746782B2 (en) 2002-05-02
ATE222501T1 (de) 2002-09-15
AU8331598A (en) 1998-12-08
NO995459D0 (no) 1999-11-08
PT980251E (pt) 2003-01-31
EP0980251A1 (de) 2000-02-23
ES2184299T3 (es) 2003-04-01
CA2288117A1 (en) 1998-11-19
DK0980251T3 (da) 2002-11-18
WO1998051321A1 (de) 1998-11-19
DE19719652A1 (de) 1998-12-03
EP0980251B1 (de) 2002-08-21
WO1998051321A9 (de) 1999-04-01
JP2001527555A (ja) 2001-12-25
NO995459L (no) 1999-11-08
CZ391299A3 (cs) 2000-04-12
SI0980251T1 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
ATE240744T1 (de) Verwendung von csf-1-inhibitoren
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE69022249D1 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE50011194D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
DE69634519D1 (de) Katheter zur ablation von atrio-ventikulären gewebe
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
DE69926385D1 (de) Behandlung von geweben
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
HUP0003831A2 (hu) Szövetfaktor alkalmazása véredényképződés befolyásolására
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
DE69832075D1 (de) Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
ATE259809T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
HUP9902933A2 (hu) Verapamil alkalmazása angina kezelésére szolgáló gyógyszer előállítására
SE9802075D0 (sv) New use
UA25252A (uk) Хірургічhий спосіб лікуваhhя захворюваhь артерій hижhіх кіhцівок
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.